down-arrowleft-arrowright-arrow

Erika Selli Partner

Erika leverages her technical background and practical trial and appellate experience on complex, large-scale litigations to develop business-oriented strategies and solutions in all aspects of her practice.

LOCATION

New York

+1.212.588.0800

745 Fifth Avenue, 10th Floor,
New York, NY 10151

VIEW IN MAPS
  • Erika Selli is a Partner at the New York office of Haug Partners and represents and advises life sciences and technology companies in the patent, regulatory, and life-cycle spaces. She has successfully leveraged her technical background in the representation of clients in intellectual property and commercial matters at every stage of litigation—from pre-suit investigation, case inception, discovery, trial and appeal—before various federal district courts, the U.S. Court of Appeals for the Federal Circuit, and the U.S. Patent and Trademark Office. Erika’s experience spans a wide variety of pharmaceuticals (e.g., antihemophilic biologics, controlled and modified-release oral dosage formulations, C1-esterase inhibitors, advanced polymer technology, antiepileptics, and peptide-based anticoagulants), as well as computer software and commercial products. In addition to her litigation practice, Erika is a Registered Patent Attorney and has substantial experience in analyzing domestic and global patent portfolio analyses, handling due diligence investigations, preparing freedom to operate and validity opinions, and assessing regulatory matters. This breadth of experience has made Erika an effective counselor and advisor to her clients by helping them identify and navigate risks in a manner consistent with their business objectives and goals. Further, she seeks to advance and improve diversity in the legal field through her participation and speaking engagements at bar and industry associations.
  • Erika earned her law degree from the St. John’s University School of Law, where she served as a member of the St. John’s Law Review and was selected as a recipient of the Ronald Brown Scholarship. During law school, she gained practical insight regarding the judicial process while interning for Magistrate Judge A. Kathleen Tomlinson of the Eastern District of New York. Before law school, Erika received her B.S. in Neuroscience magna cum laude from Union College, where she conducted federally funded research related to the embryonic development of the PPT1 gene in drosophila and subsequently interned with Brookhaven National Laboratory’s Office of Sponsored Research.
  • SuperLawyers® Rising Stars 2017-2020
  • Baxalta Inc. et al. v. Bayer HealthCare LLC, No. 17-1316 (D. Del.)
  • Bayer HealthCare LLC v. Baxalta Inc. et al., No. 16-1122 (D. Del.)
  • Bayer HealthCare LLC v. Baxalta Inc. et al., Nos. 19-2418 and 20-1017 (Fed. Cir.)
  • NOF Corporation v. Nektar Therapeutics, IPR Nos. 2019-01392, 01394, 01395, 01396, 01397, 01398 (PTAB)
  • Supernus Pharm., Inc. v. TWi Pharm., Inc. et al., No. 1:15-cv-00369 (D.N.J.)
  • CSL Behring GmBH vs. Shire ViroPharma Inc., IPR No. 2017-01512 (PTAB)
  • Shire Dev. LLC, et al. v. Watson Pharms., Inc., et al., No. 0:12-cv-60862 (S.D. Fla.), No. 16-1785 (Fed. Cir.)
  • Shire Dev. LLC, et al. v. Mylan Pharms. Inc., et al., No. 12-cv-01190 (M.D. Fla.), No. 17-2268 (Fed. Cir.)
  • Shire Dev. LLC, et al. v. Cadila Healthcare Ltd., et al., No. 10-cv-00581 (D. Del.), No. 17-1048 (Fed. Cir.)
  • The Medicines Company v. Hospira, Inc., No. 2014-1469 (Fed. Cir.)
  • The Medicines Company v. Mylan Inc., No. 11-cv-1285 (N.D. Ill.)
  • BSG Tech, LLC v. Power Equipment Direct, Inc., Case No. 15-01156 (E.D. Tex.)
  • Oberalis, LLC v. Build.com, No. 15-00962 (E.D. Tex.)
  • Genaville, LLC v. Power Equipment Direct, Inc., No. 15-00887 (E.D. Tex.)
  • Higher One Inc. v. Touchnet Info. Sys. Inc., No. 10-cv-01435 (D. Conn.)
  • GeoTag Inc. v. Frontier Communications Corp. et. al, No. 10-cv-00265 (E.D.Tex.)
  • Higher One Inc. v. Touchnet Info. Sys. Inc., No. 09-cv-00337 (D. Conn.)
  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy
  • FDA Compliance and Counseling
  • Union College, B.S., Neuroscience (2007)
  • St. John’s University School of Law, J.D. (2010)
  • New York
  • New Jersey
  • U.S. Patent and Trademark Office, Reg. No. 66,661
  • U.S. Court of Appeals for the Federal Circuit
  • Southern District of New York
  • Eastern District of New York
  • District of Connecticut
  • Eastern District of Texas
  • District of Colorado
  • Quynh Chu-LaGraff & Erika Selli, The Drosophila Palmitoyl Protein Thioesterase I, a Homologue of the Batten Disease PPT1 gene, is Required for Normal Embryonic Neural Development, 21 The Journal of the Federation of American Societies for Experimental Biology 785 (2007)
  • “What Subject Matter is Patent-Eligible?,” Connecticut Law Tribune (Oct. 10, 2011)
  • ChIPS, New York and National Chapters
  • Women, Influence & Power in Law
  • Union College, New York Alumni Chapter
  • New York Intellectual Property Association
  • National Association of Women Lawyers
  • Moderator, “Litigation Management: Managing Outside Resources and Costs,” Women, Influence & Power in Law, Washington, D.C. (Oct. 18, 2019)

+1.212.588.0800
eselli@haugpartners.com

RELATED SERVICES

  • Intellectual Property Enforcement
  • Intellectual Property Procurement and Strategy
  • FDA Compliance and Counseling

BAR ADMISSIONS

  • New York
  • New Jersey
  • U.S. Patent and Trademark Office, Reg. No. 66,661
  • U.S. Court of Appeals for the Federal Circuit
  • Southern District of New York
  • Eastern District of New York
  • District of Connecticut
  • Eastern District of Texas
  • District of Colorado

Haug Partners LLP
745 Fifth Avenue, 10th Floor,
New York, NY 10151
+1.212.588.0800
haugpartners.com

Erika Selli

Partner

HIGHLIGHT

Erika leverages her technical background and practical trial and appellate experience on complex, large-scale litigations to develop business-oriented strategies and solutions in all aspects of her practice.

OVERVIEW

Erika Selli is a Partner at the New York office of Haug Partners and represents and advises life sciences and technology companies in the patent, regulatory, and life-cycle spaces. She has successfully leveraged her technical background in the representation of clients in intellectual property and commercial matters at every stage of litigation—from pre-suit investigation, case inception, discovery, trial and appeal—before various federal district courts, the U.S. Court of Appeals for the Federal Circuit, and the U.S. Patent and Trademark Office. Erika’s experience spans a wide variety of pharmaceuticals (e.g., antihemophilic biologics, controlled and modified-release oral dosage formulations, C1-esterase inhibitors, advanced polymer technology, antiepileptics, and peptide-based anticoagulants), as well as computer software and commercial products. In addition to her litigation practice, Erika is a Registered Patent Attorney and has substantial experience in analyzing domestic and global patent portfolio analyses, handling due diligence investigations, preparing freedom to operate and validity opinions, and assessing regulatory matters. This breadth of experience has made Erika an effective counselor and advisor to her clients by helping them identify and navigate risks in a manner consistent with their business objectives and goals. Further, she seeks to advance and improve diversity in the legal field through her participation and speaking engagements at bar and industry associations.

Erika earned her law degree from the St. John’s University School of Law, where she served as a member of the St. John’s Law Review and was selected as a recipient of the Ronald Brown Scholarship. During law school, she gained practical insight regarding the judicial process while interning for Magistrate Judge A. Kathleen Tomlinson of the Eastern District of New York. Before law school, Erika received her B.S. in Neuroscience magna cum laude from Union College, where she conducted federally funded research related to the embryonic development of the PPT1 gene in drosophila and subsequently interned with Brookhaven National Laboratory’s Office of Sponsored Research.

AWARDS

  • SuperLawyers® Rising Stars 2017-2020

REPRESENTATIVE CASES

  • Baxalta Inc. et al. v. Bayer HealthCare LLC, No. 17-1316 (D. Del.)
  • Bayer HealthCare LLC v. Baxalta Inc. et al., No. 16-1122 (D. Del.)
  • Bayer HealthCare LLC v. Baxalta Inc. et al., Nos. 19-2418 and 20-1017 (Fed. Cir.)
  • NOF Corporation v. Nektar Therapeutics, IPR Nos. 2019-01392, 01394, 01395, 01396, 01397, 01398 (PTAB)
  • Supernus Pharm., Inc. v. TWi Pharm., Inc. et al., No. 1:15-cv-00369 (D.N.J.)
  • CSL Behring GmBH vs. Shire ViroPharma Inc., IPR No. 2017-01512 (PTAB)
  • Shire Dev. LLC, et al. v. Watson Pharms., Inc., et al., No. 0:12-cv-60862 (S.D. Fla.), No. 16-1785 (Fed. Cir.)
  • Shire Dev. LLC, et al. v. Mylan Pharms. Inc., et al., No. 12-cv-01190 (M.D. Fla.), No. 17-2268 (Fed. Cir.)
  • Shire Dev. LLC, et al. v. Cadila Healthcare Ltd., et al., No. 10-cv-00581 (D. Del.), No. 17-1048 (Fed. Cir.)
  • The Medicines Company v. Hospira, Inc., No. 2014-1469 (Fed. Cir.)
  • The Medicines Company v. Mylan Inc., No. 11-cv-1285 (N.D. Ill.)
  • BSG Tech, LLC v. Power Equipment Direct, Inc., Case No. 15-01156 (E.D. Tex.)
  • Oberalis, LLC v. Build.com, No. 15-00962 (E.D. Tex.)
  • Genaville, LLC v. Power Equipment Direct, Inc., No. 15-00887 (E.D. Tex.)
  • Higher One Inc. v. Touchnet Info. Sys. Inc., No. 10-cv-01435 (D. Conn.)
  • GeoTag Inc. v. Frontier Communications Corp. et. al, No. 10-cv-00265 (E.D.Tex.)
  • Higher One Inc. v. Touchnet Info. Sys. Inc., No. 09-cv-00337 (D. Conn.)

EDUCATION

  • Union College, B.S., Neuroscience (2007)
  • St. John’s University School of Law, J.D. (2010)

BAR ADMISSIONS

  • New York
  • New Jersey
  • U.S. Patent and Trademark Office, Reg. No. 66,661
  • U.S. Court of Appeals for the Federal Circuit
  • Southern District of New York
  • Eastern District of New York
  • District of Connecticut
  • Eastern District of Texas
  • District of Colorado

PUBLICATIONS

  • Quynh Chu-LaGraff & Erika Selli, The Drosophila Palmitoyl Protein Thioesterase I, a Homologue of the Batten Disease PPT1 gene, is Required for Normal Embryonic Neural Development, 21 The Journal of the Federation of American Societies for Experimental Biology 785 (2007)
  • “What Subject Matter is Patent-Eligible?,” Connecticut Law Tribune (Oct. 10, 2011)

MEMBERSHIPS

  • ChIPS, New York and National Chapters
  • Women, Influence & Power in Law
  • Union College, New York Alumni Chapter
  • New York Intellectual Property Association
  • National Association of Women Lawyers

SPEAKING ENGAGEMENTS

  • Moderator, “Litigation Management: Managing Outside Resources and Costs,” Women, Influence & Power in Law, Washington, D.C. (Oct. 18, 2019)